Please assess the completion status of the following clinical trial:

Trial Title: Changes in Serum Fibroblast Growth Factor 21 (FGF21) Levels Correlated With Exercise

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women~* Aged 18 to 35 years old,~* Body mass index (BMI) \<30 kg/m2~* Without contraindication for exercising~Exclusion Criteria:~* Metabolic syndrome~* Diabetes~* Dyslipidemia~* Hypertension~* Asthma~* Thyroid disease~* Treated with fibrates, beta agonists or blockers~* History or current arrhythmias, murmurs, cardiomegaly, or treatment for cardiovascular diseases -~* Contraindications for exercise testing were also considered as exclusion criteria (see references)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Supervised exercising (Type: EXPERIMENTAL): A treadmill exercise test (following the Bruce's protocol) was done five times per week (from Monday to Friday) for two weeks to participants.

Based on this trial design, predict the completion outcome and termination type (if applicable).